Suchergebnisse

In Her Hands examines the various strategies women have utilized to fight for recognition as individuals vulnerable to and living with HIV/AIDS across multiple settings since the 1980s. Taking a new chronological and thematic approach to the study of the US epidemic, it explores five arenas of women's AIDS activism: transmission and recognition, reproductive justice, safer sex campaigns for queer women, the carceral state, and HIV prevention and treatment. In so doing, it moves the historical understanding of women's experiences of AIDS beyond their exclusion from the initial medical response and the role women played as the supporters of gay men. Asking how and on what terms women succeeded in securing state support, In Her Hands argues that women protesting the neglect of their health-care needs always risked encountering punitive intervention on behalf of the symbolic needs of fetuses and children - as well as wider society - deemed to need protecting from them.

In Her Hands examines the various strategies women have utilized to fight for recognition as individuals vulnerable to and living with HIV/AIDS across multiple settings since the 1980s. Taking a new chronological and thematic approach to the study of the US epidemic, it explores five arenas of women's AIDS activism: transmission and recognition, reproductive justice, safer sex campaigns for queer women, the carceral state, and HIV prevention and treatment. In so doing, it moves the historical understanding of women's experiences of AIDS beyond their exclusion from the initial medical response and the role women played as the supporters of gay men. Asking how and on what terms women succeeded in securing state support, In Her Hands argues that women protesting the neglect of their health-care needs always risked encountering punitive intervention on behalf of the symbolic needs of fetuses and children - as well as wider society - deemed to need protecting from them

CONTENT: Letter from Emma D. Day to her brother Sammy Day written in April of 1889. Primarily about the health of their brother? Charlie. BIOGRAPHICAL HISTORY: The Day Family were anglo Indian traders, on the Navajo Reservation in eastern Arizona. The collection includes the personal and business papers of Sam Day, Sr. (1845-1925) surveyor, Indian trader, legislator and United States Indian Commissioner; Anna Day, Sam Sr.'s wife (1872-1932); and of their children, Charles L. Day (1879-1918), Samuel Day, Jr. (1889-1944), United States deputy Marshall. The collection includes information on Navajo culture, stories and legends; the looting of Canyon del Muerta, and the Frank Dugan murder. The collection also contains 91 photographs depicting trading posts and eastern Arizona scenes.

To what extent has the right to access generic HIV medication been implemented in Kenya for the 1.6 million people living with HIV? How does this relate to the right to health under international and national law? This paper examines a constitutional challenge brought to the High Court of Kenya in 2009 (the 'Anti-Counterfeit Case') against the Anti-Counterfeit Act of 2008, which the petitioners, all of whom were living with HIV, argued would affect their ability to access affordable and generic antiretroviral medication. They argued that this would amount to a violation of their right to life, dignity, and health. This case is particularly interesting because the new Kenyan Constitution came into force in 2010, after the case had been filed, and specifically provided for the right to health for all of Kenya's citizens, as well as giving direct effect to all international laws ratified by the Kenyan government. This paper follows the Anti-Counterfeit Case, which includes amendments filed by the petitioners following the new constitutional changes, the arguments by the different parties in the case, and the inappropriateness of counterfeit laws as measures to control substandard and falsified medicine. The case has resulted in the suspension of significant parts of the Anti-Counterfeit Act that would pose a challenge to parallel importation, and to the court issuing a directive that the sections be amended. The judgment is examined in detail, as are the broader implications of this case for other countries in Eastern Africa. Adapted from the source document.

The burden of hepatitis C infection is considerable among people who inject drugs (PWID), with an estimated prevalence of 39%, representing an estimated 6.1 million people who have recently injected drugs living with hepatitis C infection. As such, PWID are a priority population for enhancing prevention, testing, linkage to care, treatment and follow-up care in order to meet World Health Organization (WHO) hepatitis C elimination goals by 2030. There are many barriers to enhancing hepatitis C prevention and care among PWID including poor global coverage of harm reduction services, restrictive drug policies and criminalization of drug use, poor access to health services, low hepatitis C testing, linkage to care and treatment, restrictions for accessing DAA therapy, and the lack of national strategies and government investment to support WHO elimination goals. On 5 September 2017, the International Network of Hepatitis in Substance Users (INHSU) held a roundtable panel of international experts to discuss remaining challenges and future priorities for action from a health systems perspective. The WHO health systems framework comprises six core components: service delivery, health workforce, health information systems, medical procurement, health systems financing, and leadership and governance. Communication has been proposed as a seventh key element which promotes the central role of affected community engagement. This review paper presents recommended strategies for eliminating hepatitis C as a major public health threat among PWID and outlines future priorities for action within a health systems framework.

The burden of hepatitis C infection is considerable among people who inject drugs (PWID), with an estimated prevalence of 39%, representing an estimated 6.1 million people who have recently injected drugs living with hepatitis C infection. As such, PWID are a priority population for enhancing prevention, testing, linkage to care, treatment and follow‐up care in order to meet World Health Organization (WHO) hepatitis C elimination goals by 2030. There are many barriers to enhancing hepatitis C prevention and care among PWID including poor global coverage of harm reduction services, restrictive drug policies and criminalization of drug use, poor access to health services, low hepatitis C testing, linkage to care and treatment, restrictions for accessing DAA therapy, and the lack of national strategies and government investment to support WHO elimination goals. On 5 September 2017, the International Network of Hepatitis in Substance Users (INHSU) held a roundtable panel of international experts to discuss remaining challenges and future priorities for action from a health systems perspective. The WHO health systems framework comprises six core components: service delivery, health workforce, health information systems, medical procurement, health systems financing, and leadership and governance. Communication has been proposed as a seventh key element which promotes the central role of affected community engagement. This review paper presents recommended strategies for eliminating hepatitis C as a major public health threat among PWID and outlines future priorities for action within a health systems framework.

The burden of hepatitis C infection is considerable among people who inject drugs (PWID), with an estimated prevalence of greater than 40%, representing an estimated 5.6 million people who have recently injected drugs living with hepatitis C infection. As such, PWID are a priority population for enhancing prevention, testing, linkage to care, treatment and follow-up care in order to meet World Health Organization (WHO) hepatitis C elimination goals by 2030. There are many barriers to enhancing hepatitis C prevention and care among PWID including; poor global coverage of harm reduction services, restrictive drug policies and criminalization of drug use, poor access to health services, low hepatitis C testing, linkage to care and treatment, restrictions for accessing DAA therapy, and the lack of national strategies and government investment to support WHO elimination goals. On 5 September 2017, the International Network of Hepatitis in Substance Users (INHSU) held a roundtable panel of international experts to discuss remaining challenges and future priorities for action from a health systems perspective. The WHO health systems framework comprises six core components; service delivery, health workforce, health information systems, medical procurement, health systems financing, and leadership and governance. Communication has been proposed as a seventh key element which promotes the central role of affected community engagement. This review paper presents recommended strategies for eliminating hepatitis C as a major public health threat among PWID and outlines future priorities for action within a health systems framework.

Explores how public health concerns and political agendas influenced each other in the US over the past centuryProvides a comparison of the Spanish Flu and Covid-19 pandemics, giving insights into how the US government responded and what has been learned over the past centuryCovers how responses to disease have stratified society along race, gender, and class lines, furthering inequality instead of improving public healthIncludes cross-disciplinary studies, ranging from the hisoty of medicine to social history, economics and cultural studiesIncludes case studies which are based on unique research on specific threats to public health such as polio, diabetes, HIV-AIDS, and TuberculosisThe case studies critically examine the varying governmental and market-based responses to public health crises, and how these have changed and clashed over timeThis book offers an insightful discussion of the complex relationship between public health, US democracy and power during the so-called American century. It sheds light on the intricate history of the US public health system, examining how the development of the federal government has shaped its trajectory. By exploring the intertwined roles of politics, race and socio-economic factors, the contributors uncover the challenges and contradictions of public health in the US from the Spanish Flu to Covid-19. They also investigate the connections between public health and America's aspirations as a global power, as well as its domestic implications for social cohesion and institutional legitimacy. The focus on the American century provides a critical historical timeframe for an in-depth understanding of the connections between public health, people and power, on both the domestic and global stages